scispace - formally typeset
W

Wei-Wei Ren

Researcher at Tongji University

Publications -  30
Citations -  723

Wei-Wei Ren is an academic researcher from Tongji University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 10, co-authored 18 publications receiving 361 citations.

Papers
More filters
Journal ArticleDOI

Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice

TL;DR: A nanoparticle-based approach in combination with a TLR7 agonist and sonodynamic therapy is used, and it is found that when used together with anti-PD-L1, tumour formation and metastases are impacted.
Journal ArticleDOI

Extravascular gelation shrinkage-derived internal stress enables tumor starvation therapy with suppressed metastasis and recurrence

TL;DR: This starvation strategy can suppress tumor metastasis and tumor recurrence via reducing vascular density and blood supply and occluding tumor migration passages, which thus provides a promising avenue to comprehensive cancer therapy.
Journal ArticleDOI

Coordination-Responsive Longitudinal Relaxation Tuning as a Versatile MRI Sensing Protocol for Malignancy Targets.

TL;DR: With CLRT, this MRI‐based ruler is demonstrated for the successful specific detection of biological targets of malignancy, and its potential in quantitative measurement of hyaluronic acid is further demonstrated.
Journal ArticleDOI

Radiofrequency-Sensitive Longitudinal Relaxation Tuning Strategy Enabling the Visualization of Radiofrequency Ablation Intensified by Magnetic Composite.

TL;DR: A RF-sensitive magnetic composite using porous hollow iron oxide nanoparticles (HIONs) as carriers to load dl-menthol (DLM) holds a great potential in lowering the power and time of RF ablation and improving its therapeutic safety.
Journal ArticleDOI

PSA targeted dual-modality manganese oxide-mesoporous silica nanoparticles for prostate cancer imaging.

TL;DR: The data demonstrate that PSA targeted fluorescence and MR dual-functional nanoparticle can visualize prostate cancer and can be used as NIRF/MR contrast agents.